Mouse Mammary Tumor Virus Promoter-Containing Retroviral Promoter Conversion Vectors for Gene-Directed Enzyme Prodrug Therapy are Functional In Vitro and In Vivo

Gene directed-enzyme prodrug therapy (GDEPT) is an approach for sensitization of tumor cells to an enzymatically activated, otherwise nontoxic, prodrug. Cytochrome P450 2B1 (CYP2B1) metabolizes the prodrugs cyclophosphamide (CPA) and ifosfamide (IFA) to produce the cytotoxic substances phosphoramide...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Klein, Reinhard, Ruttkowski, Bärbel, Schwab, Sonja, Peterbauer, Thomas, Salmons, Brian, Günzburg, Walter H., Hohenadl, Christine
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2008
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2291507/
https://ncbi.nlm.nih.gov/pubmed/18414588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2008/683505
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars